During the last session, Oncolytics Biotech, Inc (NASDAQ:ONCY)’s traded shares were 0.37 million, with the beta value of the company hitting 0.96. At the end of the trading day, the stock’s price was $0.69, reflecting an intraday loss of -6.29% or -$0.05. The 52-week high for the ONCY share is $1.53, that puts it down -121.74 from that peak though still a striking 13.04% gain since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $53.09M, and the average trade volume was 1.23 million shares over the past three months.

Oncolytics Biotech, Inc (ONCY) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ONCY has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.

Oncolytics Biotech, Inc (NASDAQ:ONCY) trade information

Oncolytics Biotech, Inc (ONCY) registered a -6.29% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -6.29% in intraday trading to $0.69, hitting a weekly high. The stock’s 5-day price performance is 4.24%, and it has moved by -6.99% in 30 days. Based on these gigs, the overall price performance for the year is -33.13%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.01%. While earnings are projected to return 4.07% in 2025, the next five years will return 32.00% per annum.

ONCY Dividends

Oncolytics Biotech, Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 0.19 million shares, is of SEEDS INVESTOR LLC’s that is approximately 0.2496% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.19 million.

Data provided on Dec 31, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 66.94 shares. This amounts to just over 0.08 percent of the company’s overall shares, with a $46107.0 market value.